• No results found

University of Groningen Epigenetic editing Cano Rodriguez, David

N/A
N/A
Protected

Academic year: 2021

Share "University of Groningen Epigenetic editing Cano Rodriguez, David"

Copied!
9
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

University of Groningen

Epigenetic editing

Cano Rodriguez, David

IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from

it. Please check the document version below.

Document Version

Publisher's PDF, also known as Version of record

Publication date:

2017

Link to publication in University of Groningen/UMCG research database

Citation for published version (APA):

Cano Rodriguez, D. (2017). Epigenetic editing: Towards sustained gene expression reprogramming in

diseases. University of Groningen.

Copyright

Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).

Take-down policy

If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim.

Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the number of authors shown on this cover page is limited to 10 maximum.

(2)

Epigenetic Editing

Towards sustained gene expression

reprogramming in diseases

(3)

Cover design: Sebastián Suárez G. Lay out: Sebastián Suárez G. Contact: sebastians95@hotmail.com

UMCG institute PhD thesis ISBN (printed): 978-90-367-9958-4 ISBN (electronic): 978-90-367-9957-7

No parts of this thesis may be reproduced or transmitted in any form or by any means electronic or mechanical, without permission of the author.

The research described in this thesis was financially supported by the EU SNN: The northern netherlands provinces alliance.

(4)

Epigenetic Editing

Towards sustained gene expression reprogramming in diseases

PhD Thesis

To obtain the degree of PhD at the

University of Groningen

On the authority of the

Rector Magnificus Prof. E Sterken

And in accordance with

the decision of the College of Deans

This thesis will be defended in public on

Wednesday 12 July 2017 at 9:00 hours

By

David Cano-Rodriguez

Born on March 23 1987

in Cali, Colombia

(5)

Supervisor Prof. M.G. Rots Co-Promoter Dr. M.H.J Ruiters Assessment Committee Prof. T. Jurkowski Prof. E. Vellenga Prof. G. Molema

(6)

Paranymphs

Alejandro Suarez Rivillas Gabriela Tapia Calle

(7)
(8)

Chapter 1: General Introduction

Chapter 2: Epigenetic editing: On the verge of

reprogram-ming gene expression at will

Chapter 3: Re-expressing epigenetically silenced genes by

inducing DNA demethylation through targeting of Ten-Ele-ven Translocation 2 to any giTen-Ele-ven genomic locus

Chapter 4: Breaking barriers through chromatin: how can

epigenetic context predict targeting efficiency?

Chapter 5: Targeting two different promoters of

endoge-nous RASSF1 to confirm its dual role in cancer

Chapter 6: TCTN2: a novel tumor marker with oncogenic

properties

Chapter 7: Targeted epigenetic editing of SPDEF reduces

mucus production in lung epithelial cells

Chapter 8: Writing of H3K4Me3 overcomes epigenetic

si-lencing in a sustained but context-dependent manner

Chapter 9: General Discussion and Future

Perspecti-ves

Chapter 10: Summary

Appendices

Nederlandse Samenvatting List of Publications and biography Biography Acknowledgements 12 24 40 54 70 84 98 112 132 142 146 147 148 149

(9)

Referenties

GERELATEERDE DOCUMENTEN

Opportunities and Challenges of Epigenetic Editing in Human Diseases Goubert,

In this consortium, 12 PhD students from eight different countries and scientific institutes have studied the role of epigenetic regulation in resistance development for

We will determine cellular heterogeneity and sub-cell type epigenetic state switching [29] and use CRISPR-dCas9-based Epigenetic Editing [30] to locally overwrite epigenetic

(c) Relati- ve mRNA expression of ICAM1, RASSF1a, EpCAM in HEK293T and A549 cells and (d) PLOD2 in C33a cells, by the indicated dCas9 fusion protein co-transfected with a

However, modulation of the target gene by induction of histone marks in the chromatin context was demonstrated first in 2002, by inducing H3K9 methylation and causing gene

First, we reviewed in chapter 2 the most recent advances in targeting epigenetic effector domains to different regions in the genome, in order to alter gene expression..

In 2012, after finishing his master, he got the great opportunity to obtain a PhD position at the University Medical Center Groningen, from the Rijksuniversiteit Gro- ningen,

unravel the mechanisms underlying stable gene reprogramming, thus different outcomes for gene expression modulation are dependent on the local chromatin